Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer

Clinical trial NCT07104149 · RECRUITING

Trial details

NCT number: NCT07104149
Sponsor: The First Affiliated Hospital of Zhengzhou University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Female, Age ≥ 18 Years Old No Previous Systemic Treatment for the Current Disease, Including Surgery, Antitumor Radiochemotherapy/Immunotherapy ECOG Score of 0-1 Histologically Confirmed Cervical Cancer, FIGO Stage IB3, IIA2, IIB, IIIC, and Assessed by the Researcher as Resectable Lesion Sufficient Organ Function The Result of the Urine or Serum Pregnancy Test for the Subject is Negative Subjects Should Take Contraceptive Measures Locally Advanced Cervical Cancer Expected Survival Time >6 Months

Start date: 2025-03-10
Primary completion: 2026-12-31
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.